Platelet pathogen reduction sets
W81K0225QA070 · DEPT OF DEFENSE
A IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING solicitation, performed in Tripler Army Medical Center, HI, with responses due 2025-08-11. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
The Medical Readiness Contracting Office - Pacific, in support of Tripler Army Medical Center, Hawaii, intends to make a sole source award to Cerus Corporation for the purchase of Intercept platelet pathogen reduction sets for use on the government-owned Cerus Illuminator. This will be for a 12-mont
Comparable recent awards in IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| REMEL INC. | $64K | n/a | 2026-07-02 |
| CEPHEID | $306K | n/a | 2026-07-01 |
| ABBOTT LABORATORIES INC. | $102K | 1 | 2026-07-01 |
| ROCHE DIAGNOSTICS CORPORATION | $615K | 1 | 2026-07-01 |
| ABBOTT LABORATORIES INC. | $2.8M | n/a | 2026-07-01 |
Questions
What is solicitation W81K0225QA070?
Platelet pathogen reduction sets, issued by DEPT OF DEFENSE, under NAICS 325413 (IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING), performed in Tripler Army Medical Center, HI. Responses are due 2025-08-11.
What do similar contracts close for?
Comparable closed awards in this category ran from $64K to $2.8M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Is W81K0225QA070 set aside?
NONE. Check the notice on SAM.gov for the eligibility language that governs.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.